BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8606627)

  • 21. [Glucagonoma: a recent series of 7 cases].
    Vauleon E; Egreteau J; Boucher E; Desfourneaux V; Bretagne JF; Raoul JL
    Bull Cancer; 2004; 91(7-8):637-40. PubMed ID: 15381454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glucagonoma syndrome: a review of its features and discussion of new perspectives.
    Chastain MA
    Am J Med Sci; 2001 May; 321(5):306-20. PubMed ID: 11370794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagonoma syndrome: case report and literature review.
    Parker CM; Hanke CW; Madura JA; Liss EC
    J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical analysis of glucagonoma syndrome (four cases reported)].
    Ma DL; Zeng JY; Wang BX; Fang K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):210-3. PubMed ID: 12905724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature.
    Tierney EP; Badger J
    MedGenMed; 2004 Sep; 6(3):4. PubMed ID: 15520626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucagon-secreting malignant neuroendocrine tumor of the pancreas].
    Wickenhauser C; Aichelmann E; Neuhaus H; Hölscher AH; Dienes HP
    Med Klin (Munich); 2000 Aug; 95(8):466-9. PubMed ID: 10985071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glucagonoma without glucagonoma syndrome].
    Colović R; Matić S; Micev M; Grubor N; Latincić S
    Srp Arh Celok Lek; 2010; 138(3-4):244-7. PubMed ID: 20499510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Necrolytic migratory erythema].
    Dandrifosse JF; Dandrifosse AC; Piérard G; Scheen AJ; Dandrifosse G
    Rev Med Liege; 1998 Dec; 53(12):778-83. PubMed ID: 9927878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
    Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
    J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrolytic migratory erythema: case report and clinical review.
    Adam DN; Cohen PD; Ghazarian D
    J Cutan Med Surg; 2003; 7(4):333-8. PubMed ID: 14738101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Necrolytic migratory erythema as the only presenting sign of a glucagonoma.
    Johnson SM; Smoller BR; Lamps LW; Horn TD
    J Am Acad Dermatol; 2003 Aug; 49(2):325-8. PubMed ID: 12894090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
    Oberkirchner U; Linder KE; Zadrozny L; Olivry T
    Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome.
    Alexander EK; Robinson M; Staniec M; Dluhy RG
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):827-31. PubMed ID: 12460334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal endocrine tumours. Glucagonomas.
    Frankton S; Bloom SR
    Baillieres Clin Gastroenterol; 1996 Dec; 10(4):697-705. PubMed ID: 9113318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagonoma syndrome is an underdiagnosed clinical entity.
    Edney JA; Hofmann S; Thompson JS; Kessinger A
    Am J Surg; 1990 Dec; 160(6):625-8; discussion 628-9. PubMed ID: 2252125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucagonoma: evolution and treatment].
    Carvajal C; Azabache V; Lobos P; Ibarra A
    Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The glucagonoma syndrome. 3 new cases].
    Arnaud A; Fetissof F; Lorette G; Reigner J; Bertrand G; Lecomte P
    Rev Med Interne; 1992; 13(2):103-8. PubMed ID: 1410882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.